Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D levels are not linked to Alopecia Areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

PRP injections can effectively treat alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.